Physician profile
Dawn Garrett-Wright
NPI 1033509393
$733.58
in general payments reported to CMS, 2019-2025
11 companies · $17.88 in 2025
The $17.88 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $188 · 2022: $147 · 2023: $143 · 2024: $238 · 2025: $17.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $196.07 | 2021-2024 | Invega Sustenna, Invega Trinza |
| Teva Pharmaceuticals USA, INC. | $143.97 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $95.90 | 2023-2024 | Rexulti |
| Alkermes, INC. | $68.86 | 2021-2023 | Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $61.17 | 2022 | |
| Neurocrine Biosciences, INC. | $59.64 | 2024-2025 | Ingrezza |
| Vanda Pharmaceuticals INC. | $30.32 | 2024 | Fanapt |
| Indivior INC. | $23.97 | 2024 | Perseris |
| Bioxcel Therapeutics, INC. | $22.73 | 2023 | Igalmi |
| Axsome Therapeutics, INC. | $15.56 | 2024 | Auvelity |
| Abbvie INC. | $15.39 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Garrett-Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.